Company news

CalciMedica, Inc. news in 2024

CalciMedica, Inc.'s news releases, calls and decks from 2024, newest first.

View company

CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical and Corporate Updates

November 14, 2024

CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

November 12, 2024

CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer

November 6, 2024

CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting

October 29, 2024

CalciMedica Announces Proposed Public Offering of Common Stock

October 29, 2024

CalciMedica Announces Pricing of Public Offering of Common Stock

October 29, 2024

CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

October 27, 2024

CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting

October 15, 2024

CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

August 11, 2024

CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI)

July 8, 2024

CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences

July 7, 2024

CalciMedica Set to Join Russell Microcap® Index

June 30, 2024

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

June 26, 2024

CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

June 25, 2024

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

May 12, 2024

CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024

May 6, 2024

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis

April 23, 2024

CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates

March 27, 2024

CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference

March 12, 2024

CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference

February 27, 2024

CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney Injury

February 12, 2024

CalciMedica Announces Private Placement of up to Approximately $55 Million

January 21, 2024

Decks in 2024